Almirall
Update in progressALM.MC (MCE)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
Almirall, S.A. is a skin-health focused biopharmaceutical company headquartered in Barcelona, Spain, with operations in Europe, the Middle East, the United States, Asia and Africa. It develops and markets medicines for skin diseases such as psoriasis, atopic dermatitis, acne, actinic keratosis, onychomycosis and androgenic alopecia, plus therapies across metabolism, infections, cardiovascular and nervous systems. It collaborates with Evotec, Ichnos, Simcere, Etherna, Novo Nordisk and Eloxx. Founded 1943.
Company score
- Sentiment
- 0.32
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.25
- Governance
- 0.07
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.09
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.20
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketMCE (MCE)
- LocationSpain
- CEOMr. Carlos Gallardo Piqué
- Founded1943
- Employees2,097
- Websitewww.almirall.com
Identifiers
- ISINES0157097017
- FIGIBBG000CFW9W2
- LEI95980020140005007996